Oncology & Cancer

New pharmacon allows testicular tumors to shrink

Testicular cancer is the most common malignant tumor disease in men between 20 and 40 years of age. It can usually be treated well. In some cases, however, the cancer hardly responds or does not respond at all to treatment. ...

page 6 from 10